Guardant Health officer gets 7,414 shares via RSUs
Guardant Health, Inc. Chief Commercial Officer Chris Freeman reported compensation-related equity activity involving restricted stock units.
Rhea-AI Filing Summary
Guardant Health, Inc. Chief Commercial Officer Chris Freeman reported compensation-related equity activity involving restricted stock units. On July 1, 2026, RSU awards vested and were converted into a total of 7,414 shares of common stock, reflecting derivative exercises rather than open-market purchases.
To cover tax obligations arising from this vesting, 3,141 shares of common stock were retained by the company at a value of $170.77 per share, as noted in the footnotes. The transactions do not include any open-market buying or selling, and are characterized as routine equity compensation and tax withholding events.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 1,928 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 1,667 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 2,526 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 1,293 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,928 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,667 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,526 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,293 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 3,141 | $170.77 | $536K |
Footnotes (6)
- F1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
- F2. This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
- F3. Not applicable for Restricted Stock Units.
- F4. This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- F5. This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- F6. This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.
Key Figures
Key Terms
Restricted Stock Units financial
tax withholding obligations financial
derivative security financial
restricted stock unit award financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Guardant Health (GH) report for Chris Freeman?
What do the F and M transaction codes mean in Chris Freeman’s Guardant Health filing?
Are Chris Freeman’s Guardant Health RSUs subject to time-based vesting schedules?
AI-generated analysis. How Rhea-AI works. Not financial advice.